Short-term efficacy and influencing factors of conventional chemotherapy combined with irinotecan in patients with advanced gastric cancer

Table 1 Comparison of clinical general data between the observation and control groups

Clinical general data	Observation group (n = 40)	Control group (n = 40)	t/χ2 value	P value
Gender, n (%)			0.050	0.823
Male	22 (55.00)	21 (52.50)
Female	18 (45.00)	19 (47.50)
Age (yr)	62.21 ± 7.78	61.10 ± 8.43	0.612	0.542
Body mass index (kg/m2)	22.40 ± 2.05	22.16 ± 1.95	0.536	0.593
KPS score (points)	72.21 ± 5.54	71.19 ± 5.80	0.804	0.424
TNM stage, n (%)			0.238	0.626
IIIb	27 (67.50)	29 (72.50)
IV	13 (32.50)	11 (27.50)

KPS: Karnofsky Performance Scale; TNM: Tumor node metastasis.